BAP1 and B-cell non-Hodgkin lymphoma: To further explore the roles and mechanisms of BAP1 activity in B cells, we targeted Bap1 gene using CRISPR/Cas9 in the CH12F3 B cell lymphoma line (56), which is a commonly used model for the analyses of B cell activation, class switching, and associated cellular processes.